Understanding Levitra Professional Dosage Strength

Guanylate Cyclase (GC) Stimulators, such as riociguat: Concomitant use is contraindicated [see Contraindications (4.2)]. CYP3A4 Inhibitors: The dosage of LEVITRA may require adjustment in patients receiving potent CYP3A4 inhibitors such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, atazanavir, and clarithromycin as well as in other patients receiving moderate CYP3A4 inhibitors such as erythromycin [see Drug Interactions (7.2)].

Closed Captioning

Hepatic Impairment: For patients with moderate hepatic impairment (Child-Pugh B), a starting dose of 5 mg LEVITRA is recommended. The maximum dose in patients with moderate hepatic impairment should not exceed 10 mg. Do not use LEVITRA in patients with severe hepatic impairment (Child-Pugh C) [see Warnings and Precautions (5.8), Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)]. Renal Impairment: Do not use LEVITRA in patients on renal dialysis [see Warnings and Precautions (5.9), Use in Specific Populations (8.7) and Clinical Pharmacology (12.3)]. Nitrates: Concomitant use with nitrates and nitric oxide donors in any form is contraindicated [see Contraindications (4.1)]. For ritonavir, a single dose of 2.5 mg LEVITRA should not be exceeded in a 72-hour period.

For indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, and clarithromycin, a single dose of 2.5 mg LEVITRA should not be exceeded in a 24-hour period.

Side Effects

Goal of episode: To develop a baseline knowledge on Superior Capsule Reconstruction NailedIt Ortho reports no relevant financial disclosures. Dr. Cole and Dr. Fitts report no relevant disclosures. This podcast is NOT medical advice, the podcast is for educational purposes only.

12.1 Levitra Mechanism of Action

Please consult your doctor prior to making any medical decisions. Package insert / product label Generic name: vardenafil hydrochloride Dosage form: tablet, film coated Drug class: Impotence medications The Levitra brand name has been discontinued in the U.S. LEVITRA (vardenafil hydrochloride) tablets, for oral use LEVITRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction. LEVITRA is taken as needed: For most patients, the starting dose is 10 mg, up to once daily. Increase to 20 mg or decrease to 5 mg based on efficacy/tolerability. For ketoconazole 200 mg daily, itraconazole 200 mg daily, and erythromycin, a single dose of 5 mg LEVITRA should not be exceeded in a 24-hour period.

How to take Levitra Professional

For most patients, the recommended starting dose of LEVITRA is 10 mg, taken orally, as needed, approximately 60 minutes before sexual activity. The dose may be increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and side effects. The maximum recommended dosing frequency is once per day. Sexual stimulation is required for a response to treatment. Geriatrics: A starting dose of 5 mg LEVITRA should be considered in patients ≥ 65 years of age [see Use in Specific Populations (8.5)]. Alpha-Blockers: In those patients who are stable on alpha-blocker therapy, phosphodiesterase type 5 (PDE5) inhibitors should be initiated at the lowest recommended starting dose. Concomitant treatment should be initiated only if the patient is stable on his alpha-blocker therapy.

10. Overdosage

A starting dose of 5 mg LEVITRA should be considered in patients ≥ 65 years of age. LEVITRA is taken orally, approximately 60 minutes before sexual activity. The maximum recommended dosing frequency is one tablet per day. LEVITRA may be taken with or without food. If taking potent or moderate inhibitors of CYP3A4, the dose of LEVITRA should be adjusted as follows (2.4, 5.2, 7.2): •Ritonavir: No more than 2.5 mg in a 72-hour period•Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, clarithromycin: No more than 2.5 mg in a 24-hour period Ritonavir: No more than 2.5 mg in a 72-hour period Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, clarithromycin: No more than 2.5 mg in a 24-hour period Ketoconazole 200 mg daily, itraconazole 200 mg daily, erythromycin: No more than 5 mg in a 24-hour period.

How is vardenafil supplied (dosage forms)?

In patients on stable alpha-blocker therapy the recommended starting dose of LEVITRA is 5 mg (2.4, 5.6) The recommended starting dose of LEVITRA is 5 mg in patients with moderate hepatic impairment (Child-Pugh B). The maximum dose in patients with moderate hepatic impairment should not exceed 10 mg. (2.3, 8.6) LEVITRA tablets 5 mg, 10 mg, 20 mg (3) Cardiovascular Effects: Patients should not use LEVITRA if sex is inadvisable due to cardiovascular status. Risk of Priapism: In the event that an erection lasts more than 4 hours, the patient should seek immediate medical assistance. Effects on the Eye: Patients should stop use of LEVITRA, and seek medical attention in the event of sudden loss of vision in one or both eyes, which could be a sign of nonarteritic anterior ischemic optic neuropathy (NAION). Stepwise increase in alpha-blocker dose may be associated with further lowering of blood pressure in patients taking a phosphodiesterase (PDE5) inhibitor including vardenafil. In those patients who are stable on alpha-blocker therapy, LEVITRA should be initiated at a dose of 5 mg (2.5 mg when used concomitantly with certain CYP3A4 inhibitors). [See Warnings and Precautions (5.6) and Drug Interactions (7.1).] A time interval between dosing should be considered when Levitra is prescribed concomitantly with alpha-blocker therapy [see Clinical Pharmacology (12.2)]. LEVITRA is formulated as orange, round, film-coated tablets with “BAYER” cross debossed on one side and “5”, “10” and “20” on the other side corresponding to 5 mg, 10 mg, and 20 mg of vardenafil, respectively.

• Counseling or psychological therapy may benefit those with psychological ED factors.
• Levitra Professional 20mg is part of an overall approach to sexual health.
• Regular check-ups are recommended to monitor efficacy and safety.

Administration of LEVITRA with nitrates (either regularly and/or intermittently) and nitric oxide donors is contraindicated [see Clinical Pharmacology (12.2)].

Consistent with the effects of PDE5 inhibition on the nitric oxide/cyclic guanosine monophosphate pathway, PDE5 inhibitors, including LEVITRA, may potentiate the hypotensive effects of nitrates. A suitable time interval following dosing of LEVITRA for the safe administration of nitrates or nitric oxide donors has not been determined.

¿Qué debo evitar mientras utilizo vardenafil?

There are other diet and lifestyle changes you can make along with taking Levitra to help treat your ED symptoms, including: keeping your weight at a healthy level getting enough sleep every night (6 to 9 hours) at consistent times exercising regularly for 15 to 20 minutes a day, especially aerobic exercises like running and swimming that help improve oxygen levels in your blood Like other PDE5 inhibitors, Levitra is often a relatively safe and effective way to treat ED along with dietary and lifestyle changes. Just keep in mind that ED medication alone can’t always resolve ED symptoms. There are sometimes other, less obvious reasons for an inability to get or keep an erection that are out of your control. Talk to your doctor or urologist to help uncover any underlying physical or psychological causes of ED that may be causing your symptoms. A combination of treatments may help you to have satisfying sex again.

Can Cialis and Levitra be used together?

Listen to our episode on Superior Capsule Reconstruction as Dr. Mitchell gives us an excellent overview! Dr. Mitchell, who specializes in Orthopaedic Sports Medicine, is a board certified Orthopaedic Surgeon in LaCrosse, WI. He completed his residency at University of Colorado Hospital and his fellowship training at Steadman Clinic, Steadman Philippon Research Institute. The evaluation of erectile dysfunction should include a medical assessment, a determination of potential underlying causes and the identification of appropriate treatment. Before prescribing LEVITRA, it is important to note the following: Physicians should consider the cardiovascular status of their patients, since there is a degree of cardiac risk associated with sexual activity. Therefore, treatment for erectile dysfunction, including LEVITRA, should not be used in men for whom sexual activity is not recommended because of their underlying cardiovascular status.

• The medication is designed to provide a reliable solution for ED issues.
• It is often chosen for its rapid onset of action and longer duration.
• Follow your healthcare provider's instructions for optimal outcomes.

There are no controlled clinical data on the safety or efficacy of vardenafil in the following patients; and therefore its use is not recommended until further information is available: unstable angina; hypotension (resting systolic blood pressure of <90 mmHg); uncontrolled hypertension (>170/110 mmHg); recent history of stroke, life-threatening arrhythmia, or myocardial infarction (within the last 6 months); severe cardiac failure. Patients with left ventricular outflow obstruction, (for example, aortic stenosis and idiopathic hypertrophic subaortic stenosis) can be sensitive to the action of vasodilators including PDE5 inhibitors. LEVITRA has systemic vasodilatory properties that resulted in transient decreases in supine blood pressure in healthy volunteers (mean maximum decrease of 7 mmHg systolic and 8 mmHg diastolic) [see Clinical Pharmacology (12.2)].

Trial purpose

LEVITRA should be used with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION. Patients with a “crowded” optic disc may also be at an increased risk of NAION. Sudden Hearing Loss: Patients should stop LEVITRA and seek medical attention in the event of sudden decrease or loss in hearing. Alpha-Blockers: Caution is advised when PDE5 inhibitors are co-administered with alpha-blockers. In some patients, concomitant use of these two drug classes can lower blood pressure significantly leading to symptomatic hypotension (for example, fainting).

Adverse Reactions/Side Effects

QT Prolongation: Patients with congenital QT syndrome or taking class IA or III antiarrhythmics should avoid using LEVITRA. Most common adverse reactions reported ( ≥ 2% of patients) are headache, flushing, nasal congestion, dyspepsia, sinusitis, flu syndrome, dizziness, increased creatine kinase, nausea, back pain. To report SUSPECTED ADVERSE REACTIONS, contact BayerHealthCare Pharmaceuticals1-888-84-BAYER or FDA at 1-800-FDA-1088 or LEVITRA can potentiate the hypotensive effects of nitrates, alpha-blockers, and antihypertensives. See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling. LEVITRA® is indicated for the treatment levitra 40 mg online of erectile dysfunction.